Ref ID: 19375
Author:
L. A. Long,1 N. Isham,1 G. Stoll,1 S. A. Gueye,2 E. Ghelardi,2 F.
Celandroni,2 F. Mailland,3 A. Bulgheroni3 and M. A. Ghannoum1
Author address:
1Case Western Reserve University, Cleveland, USA; 2Department
of Translational Research NTMS, University of Pisa, Italy and
3Polichem SA, Lugano-Pazzallo, Switzerland
Full conference title:
6th Trends in Medical Mycology 2013
Date: 11 October 2014
Abstract:
Objectives (1) To evaluate the antifungal activity of P-27530
against a broad range of yeast and filamentous fungi, by minimum
inhibitory concentration (MIC) assay. (2) To evaluate the natural
resistance frequency and the evolution to resistance of P-27530 in T.
rubrum, compared to amorolfine, terbinafine, itraconazole and
ciclopirox.
Methods (1) Test isolates included 5 clinical isolates each (3 suscep-
tible and 2 resistant strains where possible) of yeasts (Candida albi-
cans, C. glabrata, C. parapsislosis, C. krusei, C. lusitaniae, C. tropicalis
and Cryptococcus neoformans), moulds (Fusarium solani, Aspergillus fla-
vus, A. fumigatus, A. niger, A. terreus, Pseudallescheria boydii, Scopulari-
opsis brevicaulis, Scedosporium spp., S. prolificans, Cunninghamella
bertholletiae, Rizopus oryzae, Mucor plumbeus, M. fragilis) and dermato-
phytes (Trichophyton rubrum, T. mentagrophytes, Epidermophyton flocco-
sum, Microsporum canis). MIC testing was performed according to the
CLSI M27-A3 and M38-A2 standards for the susceptibility testing of
yeasts and filamentous fungi, respectively. (2) The frequency of spon-
taneous resistance of 3 T. rubrum strains was evaluated by counting
the number of colonies obtained following incubation of agar plates
inoculated with a total of about 109 CFU on agar plates containing drug concentrations higher than the minimal fungicidal concentra-
tion; the evolution of resistance was evaluated in 2 T. rubrum strains
serially propagated for 10 transfers on agar plates containing sub-
inhibitory drug concentrations. After the 5th and the 10th transfer,
colonies were transferred on plates containing inhibitory drug con-
centrations and assessed for growth following incubation.
Results (1) The in vitro susceptibility of the tested strains to P-
27530 was as follows: Yeasts P-27530 MIC range of 0.06-1 lg/ml
was recorded, following 24 hours incubation, for all yeasts but sev-
eral C. glabrata isolates which were read at 48 hours (MIC range of
0.06-2 lg/ml). P-27530 performed similarly against both Candida
susceptible strains and strains resistant to caspofungin, fluconazole,
miconazole, and voriconazole. Slightly reduced activity was
observed against Cryptococcus neoformans with a MIC range of 2-
4 lg/ml. Moulds P-27530 performed similarly against the suscepti-
ble strains and the strains with elevated MICs to amphotericin B,
caspofungin, itraconazole, and miconazole with a MIC range of
0.06-2 lg/ml. Dermatophytes P-27530 demonstrated similar activ-
ity against the isolates (range of 0.25-2 lg/ml) and performed simi-
larly (within one dilution) against both susceptible and resistant
(terbinafine and fluconazole) T. rubrum and T. mentagrophytes
strains. (2) no spontaneous resistant mutant to P-27530 and CPX
was isolated; resistance frequency was 107 for itraconazole and
109 for terbinafine and amorolfine. All mutants collected con-
firmed the loss of susceptibility. P-27530 and CPX did not induce
any resistance; frequency was 105 for itraconazole and 107 for
terbinafine and amorolfine. In both experiments itraconazole resis-
tant mutants showed increased resistance also to amorolfine and
terbinafine.
Conclusions P-27530 shows a good antifungal activity in vitro
against a broad spectrum of yeasts, moulds and dermatophytes, with-
out evidencing any cross-resistance potential. Moreover, the lack of
resistant mutant isolation in the in vitro assays suggests a low pro-pensity of T. rubrum to develop resistance against P-27530.
Abstract Number: p007
Conference Year: 2013
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Mrs Ange Brennan (UK)
2024
n/a
-
v
Tianyu Lianga, Nir Osherovb, Ruoyu Lia, Qiqi Wanga, Wei Chena, Zhe Wana, Wei Liua*
2024
n/a
-
v
Jillian Simard, MD,1 Christopher Melani, MD,2
Rahul Lakhotia, MD,1
Michail S. Lionakis, MD
ScD,*,3
Stefania Pittaluga, MD PhD,4
James D. Phelan, PhD,*,1 Jagan R. Muppidi, MD
PhD,*,1
Lydia L. Chou, CRNP,*,1
Matthias Holdhoff, MD PhD,*,5 Michael Glantz, MD PhD,*,6
John A. Butman, MD PhD,*,7 Andrea Nicole Lucas, RN,*,8
Seth M. Steinberg, PhD,*,9
Elaine
S. Jaffe, MD,4
Louis M. Staudt, MD PhD,1
Wyndham H. Wilson, MD PhD,1 Mark Roschewski, MD102020
n/a
-
v
Mark Roschewski, MD,1
Christopher Melani, MD,2
Rahul Lakhotia, MD,3
Stefania Pittaluga, MD
PhD,4
James D. Phelan, PhD,*,3
Cody Peer, PhD,*,5 Michail S. Lionakis, MD ScD,*,6 Lydia
L. Chou, CRNP,*,3 Matthias Holdhoff, MD PhD,*,7 Michael Glantz, MD PhD,*,8 Jan Drappatz, MD,*,9
Catherine Lai, MD MPH,10 John A. Butman, MD PhD,*,11 Andrea Nicole Lucas, RN,*,12 Seth
M. Steinberg, PhD,*,13 William D. Figg, PhD,*,14 Elaine S. Jaffe, MD,4
S. Percy Ivy, MD,*,15
Richard F. Little, MDMPH,16 Louis M. Staudt, MD PhD,3
Wyndham H. Wilson, MD PhD32020
n/a
-
v
Binav Baral, MD,*,1 Prasanth Lingamaneni,*,2 Trilok Shrivastava, MD,*,3 Maryam Zia,4 Ishaan Vohra, MD,*,2
Krishna Rekha Moturi*,32020
903
n/a
-
v
Maxwell Green1, Scout Treadwell1, Geetha Gowda1, John Carlson, MD, PhD2
2023
610
n/a
-
v
Catherine Blackwood, PhD1 , Angela Lemons, MS2 , Rachael Rush3 , Walter McKinney2 , Dori Germolec4 , Donald Beezhold, PhD2 , Brett Green, PhD5 , Tara Croston, PhD6
2023
583
n/a
-
v
Catherine Blackwood, PhD1 , Angela Lemons, MS2 , Rachael Rush3 , Walter McKinney2 , Dori Germolec4 , Donald Beezhold, PhD2 , Brett Green, PhD5 , Tara Croston, PhD6
2023
583
n/a
-
v
Jennifer Roper, MD1, Sebastian Ochoa, MD2, Anahita
Agharahimi, MSN, CRNP2, Justina Pfister, RN2, Magdalena
Walkiewicz, PhD2, Amanda Urban, DNP, CRNP3, Rajarshi
Ghosh, PhD2, Michail Lionakis, MD, ScD2, Lisa Kohn, MD, PhD4, Kenneth Olivier, MD, MPH2, Alexandra Freeman, MD22023
516
n/a
-
v
Utkucan Acar, Gloria Sheng, Terrie Ahn, Lisa Kohn, Maria Garcia Lloret, Manish Butte
2022
82
n/a